BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15116381)

  • 1. Mycophenolate mofetil in dysimmune neuropathies: a preliminary study.
    Benedetti L; Grandis M; Nobbio L; Beronio A; Ghiglione E; Manzino M; Primavera A; Mancardi G; Schenone A
    Muscle Nerve; 2004 May; 29(5):748-9. PubMed ID: 15116381
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study.
    Radziwill AJ; Schweikert K; Kuntzer T; Fuhr P; Steck AJ
    Eur Neurol; 2006; 56(1):37-8. PubMed ID: 16914929
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.
    Gorson KC; Amato AA; Ropper AH
    Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyradiculoneuropathy, in an 8-year-old girl, complicated by deafness and kidney fibrosis.
    Stojanovic VD; Doronjski AR; Spasojevic SD; Pavlovic VS; Nikolic MM; Kovacevic BB
    J Child Neurol; 2009 Aug; 24(8):997-1000. PubMed ID: 19240045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate in treatment-resistant inflammatory neuropathies.
    Umapathi T; Hughes R
    Eur J Neurol; 2002 Nov; 9(6):683-5. PubMed ID: 12453086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic.
    Lai WW; Ubogu EE
    J Neurol Sci; 2007 Sep; 260(1-2):267-70. PubMed ID: 17521674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil (MMF) therapeutic approach in patients with chronic glomerulonephritis (GN).
    Bullo B; Zdrojewski Z; Rutkowski B
    Kidney Int; 2003 Sep; 64(3):1139. PubMed ID: 12911571
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolic Acid reaches therapeutic levels whereas mycophenolate mofetil does not.
    Vilalta Casas R; Vila López A; Nieto Rey JL; Lara Moctezuma LE; Madrid Aris A; Quintana Montero M; Pou Clave L
    Transplant Proc; 2006 Oct; 38(8):2400-1. PubMed ID: 17097947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
    Harboe E; Gøransson L; Wildhagen K; Omdal R
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil: new applications for this immunosuppressant.
    Moder KG
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil in chronic glomerular diseases.
    Oliveira Sá H; Mendes T
    Nefrologia; 2008; 28(1):82-92. PubMed ID: 18336137
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
    Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
    J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.